Joseph L. Fink III, BSPharm, JD

In a case alleging injuries due to off-label use, does a pharmacist have the requisite credentials to act as an expert witness?

When a patient is harmed by a prescribing decision, who is most responsible for knowing the patient's medical history?

When a foreign company ships prescription medications to the United States for repackaging and resale, how do FDA regulations apply?

In a case of accused negligence in a nursing home, do state regulations establish a legal standard of care?

In cases alleging negligence by a pharmacist when dispensing medication, may a physician be considered an expert witness?

Should the terminally ill have special access to experimental drugs?

A case against a physician accused of "selling" prescriptions prompts debate over whether information gathered from a computer database may be used as evidence at trial.

A case before the West Virginia State Supreme Court examines whether the legislature's Medical Professional Liability Act—enacted to place limits on damage awards in malpractice lawsuits—extends the statute's protections to pharmacies.

Courts have had opportunities to rule on the position taken by the FDA in more than 20 cases to date, with a fairly even split in the decisions.

Dr. Fink is professor of pharmacy law and policy at the University of Kentucky College of Pharmacy, Lexington.

Dr. Fink is professor of pharmacy law and policy at the University of Kentucky College of Pharmacy, Lexington.

Dr. Fink is professor of pharmacy law and policy at the University of Kentucky College of Pharmacy, Lexington.